Sotabase

Career

· Research Intern, Meta AI2024–2024
· PhD student at BAIR/Sky Computing Lab, UC Berkeley2023–

Publications (29)

Potential anxiolytic agents. Part 4: novel orally-active N(5)-substituted pyrido[1,2-a]benzimidazoles with high GABA-A receptor affinity.
Bioorganic & Medicinal Chemistry Letters · 2002
31
cited
In Vitro Drug Metabolite Profiling Using Hepatic S9 and Human Liver Microsomes
2004
24
cited
Metabolism and excretion of the antiepileptic/antimigraine drug, topiramate in animals and humans
European journal of drug metabolism and pharmacokinetics · 2005
20
cited
In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone
Xenobiotica; the fate of foreign compounds in biological systems · 2002
16
cited
The in vitro metabolism of thalicarpine, an aporphine-benzyltetrahydroisoquinoline alkaloid, in the rat. API-MS/MS identification of thalicarpine and metabolites.
Journal of Pharmaceutical and Biomedical Analysis · 2002
16
cited
API-ionspray MS and MS/MS study on the structural characterization of bisbenzylisoquinoline alkaloids.
Journal of Pharmaceutical and Biomedical Analysis · 2004
15
cited
Electrospray Tandem Mass Spectrometry for Structural Characterization of Aporphine-Benzylisoquinoline Alkaloids
European Journal of Mass Spectrometry · 2004
15
cited
Structural Elucidation of Isoquinoline, Isoquinolone, Benzylisoquinoline, Aporphine, and Phenanthrene Alkaloids Using API-ionspray Tandem Mass Spectrometry
2006
11
cited
Hepatic biotransformation of the new calcium‐mimetic agent, RWJ‐68025, in the rat and in man — API‐MS/MS identification of metabolites
The Journal of pharmacy and pharmacology · 2003
10
cited
In‐vitro metabolism of isotetrandrine, a bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high‐performance liquid chromatography‐atmospheric pressure ionization mass spectrometry
The Journal of pharmacy and pharmacology · 2004
9
cited
The synthesis and evaluation of the major metabolites of mazapertine
1997
9
cited
N-Alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, μ and δ opioid agonists: a μ address
2004
8
cited
Potential Anxiolytic Agents. Part 4. Novel Orally-Active N5-Substituted Pyrido[1,2-a]benzimidazoles with High GABA-A Receptor Affinity.
2002
8
cited
In vitro metabolism of the new anxiolytic agent, RWJ-52763 in human hepatic S9 fraction-API-MS/MS identification of metabolites.
Journal of Pharmaceutical and Biomedical Analysis · 2003
7
cited
Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism
European journal of drug metabolism and pharmacokinetics · 2006
3
cited
API-ionspray Tandem Mass Spectrometric Analysis of Protopine and Oxyberberine Alkaloids
2007
2
cited
Hepatic in Vitro Metabolism of Etoperidone, an Antidepressant Drug, in the Rat and Human
2007
2
cited
In‐vitro metabolism of the new anxiolytic agent, RWJ‐50172, in rat hepatic S9 fraction and microbial transformation in fungi, Cunninghamella sp.
The Journal of pharmacy and pharmacology · 2003
2
cited
Metabolic fate of the antipsychotic agent, mazapertine, in man — API-MS and MS/MS identification of urinary metabolites
European journal of drug metabolism and pharmacokinetics · 2007
2
cited
Structural Characterization of Flavonols and Flavanones in Nanogram Quantities by API-ionspray Tandem Mass Spectrometry
2005
2
cited
Sotabase
Tsung-Han (Patrick) Wu | Researcher Profile | Sotabase | Sotabase